ISPE, in conjunction with McKinsey & Co., will release preliminary data and findings from its Quality Metrics Pilot Program at ISPE Quality Metrics Summit, April 21–22. Pilot data and findings will provide insight on what may be collected, how it may impact how pharmaceutical companies are regulated, and how quality might be measured. During summit, participants will hear case studies from some of the 18 companies and 44 individual sites who participated in the pilot.